← All trials
NCT05918939
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 5, 2022
- Primary completion
- Aug 5, 2023
- Completion date
- Sep 5, 2023
- First posted
- Jun 26, 2023
- Last posted
- Jun 26, 2023
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dr. Soetomo General HospitalLead sponsor
- Government of IndonesiaCollaborator
- Airlangga UniversityCollaborator
- Dr. Soetomo General HospitalOverall official - principal investigator
- Biotis Pharmaceuticals, IndonesiaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.